secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2022-07-29T23:59:59+00:00
Accession:  0001854270-22-000010
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences COO Curt A. Herberts III resigns effective August 19, 2022
----------------------------------------------------------------------------

- Curt A. Herberts III notified his resignation as Chief Operating Officer on July 26, 2022.
- Resignation is effective as of August 19, 2022; no reason for departure was disclosed.
- No successor or interim COO has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000185427022000010/0001854270-22-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000185427022000010/snti-20220726.htm
  HTML page:      https://secwatch.observer/filing/0001854270-22-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer